We have updated the ordering process to allow all products and services to be purchased with a single PO, please address all POs to Horizon Discovery Biosciences Limited. Contact us for assistance.

Preclinical scale and OEM RNA and DNA synthesis

Request pricing

Quality custom oligonucleotides for research and preclinical applications

Our preclinical/OEM manufacturing service provides our academic and industry partners with cost-effective and timely oligonucleotide materials for novel research (in vitro) thru preclinical use (in vivo).

Oligo manufacturing from Dharmacon offers:

  • An ISO 9001-certified manufacturing facility and a highly trained and dedicated custom oligonucleotide synthesis team
  • Preclinical scale synthesis (50 mg to multiple grams) of both RNA and DNA oligonucleotides synthesized by our proprietary 2’-ACE or traditional 2’-TBDMS chemistry
  • An extensive selection of chemical modifications such as modified nucleobases, phosphorothioates, linkers, spacers, and fluorescent dyes
  • Customization and contract production, including OEM oligonucleotide reagents to meet customer needs

Are you interested in a preclinical/OEM custom service? To get started, please request pricing with our custom oligonucleotide synthesis form. For further assistance, please contact Technical Support

Purified 42-mer crRNA
A
9A4961F910E84065AC100DE7ED96671F
B
analysis 42 mer oligo anion exchange hplc 
C
analysis 42 mer oligo mass 

Purity analysis and characterization of a 42-mer crRNA oligonucleotide. The 42-mer RNA was synthesized using 2’-O-TBDMS chemistry at 120 µmol scale. After cleavage and deprotection, the RNA oligonucleotide was purified by anion-exchange chromatography. Pooled fractions were desalted by ultra-filtration followed by freeze drying to yield lyophilized RNA. (A) Analytical ion-pairing reverse phase UPLC trace showing 92% full-length product (FLP); (B) Analytical anion-exchange HPLC trace showing 89% full-length product (FLP); (C) Mass was analyzed with the LXQ Mass Spectrometer, confirming the correct mass.

Purified 30-mer DNA
A
analysis 30 mer oligo 
B

analysis 30 mer oligo mass

Analysis of a 30-mer DNA oligonucleotide with final delivery yield of 1 g. (A) Analytical trace from ion pairing reverse phase UPLC showing 97% full length material. (B) Mass was analyzed by ESI-MS, results illustrate the correct mass.

  

 

Brochures & flyers

Custom synthesisDharmacon custom RNA synthesis enables additional experimental abilities and scientific discoveries through unique chemistry.Preclinical oligoProduct flyer giving an overview of the the preclinical oligo offering.

 

Featured articles

A role for modified synthetic RNA oligos in structural studiesDharmacon's custom RNA synthesis provides a convenient option for your structural experiments.Custom RNA synthesis resourcesWe've made it easier to understand and choose modifications for siRNA, ssRNA, 5', 3' & internal bases, and labels and dyes!Custom RNA you can SEECy Dye RNA labeling enables you to track your RNAOur patented 2'-ACE chemistry enables advanced RNA synthesisLongest RNA molecules synthetically possible with virtually any chemical modification!

 

Product inserts

Option A1 custom siRNA synthesisOption A1 custom siRNA synthesis product insert, containing contents, protocol, shipping and storage conditions, handling precautions, etc.Option A4 custom siRNA synthesisOption A4 custom siRNA synthesis product insert, containing contents, protocol, shipping and storage conditions, handling precautions, etc.Option in vivo and in vivo HPLC custom siRNA synthesisDharmacon option in vivo: The siRNA is shipped as a lyophilized pellet in the 2'- deprotected and duplexed form.

Protocols

Deprotection of 2'-ACE protected RNAHow to deprotect 2'-ACE protected RNAEthanol precipitation of RNA oligonucleotidesThis protocol is for Ethanol Precipitation of RNA Oligonucleotides.Receiving RNAProtocol for deprotecting custom synthesized RNA oligos.Reverse phase cartridge desalting of RNA oligonucleotidesProtocol for desalting RNA oligos using reverse phase cartridges, including protocol for cartridge equilibration, washing, and eluting from cartridge.TCEP reaction for thiol-modified siRNA/RNA oligonucleotidesProtocol to deprotect (reduce) oxidizied thiol-modified siRNA and RNA oligonucleotides.

Recommended reading

Dharmacon publicationsThese publications are from Dharmacon scientists highlighting internal research and collaborations in the fields of CRISPR-Cas9, RNAi, et al.

Safety data sheets

SDS (US) RNA oligonucleotidesNorth American standard safety data sheet for RNA oligonucleotides. 

SDS (US) deprotection bufferNorth American standard safety data sheet for deprotection buffer.SDS (EU) RNA oligonucleotidesEuropean Union standard safety data sheet for RNA oligonucleotides. 

SDS (EU) deprotection bufferEuropean Union standard safety data sheet for deprotection buffer.